Policymakers require estimates of the future number of cancer patients in order to allocate finite resources to cancer prevention, treatment and palliative care. We examine recent cancer incidence trends in Iran and present predicted incidence rates and new cases for the entire country for the year 2025. We developed a method for approximating population‐based incidence from the pathology‐based data series available nationally for the years 2008 to 2013, and augmented this with data from the Iranian National Population‐based Cancer Registry (INPCR) for the years 2014 to 2016. We fitted time‐linear age‐period models to the recent incidence trends to quantify the future cancer incidence burden to the year 2025, delineating the contribution of changes due to risk and those due to demographic change. The number of new cancer cases is predicted to increase in Iran from 112 000 recorded cases in 2016 to an estimated 160 000 in 2025, a 42.6% increase, of which 13.9% and 28.7% were attributed to changes in risk and population structure, respectively. In terms of specific cancers, the greatest increases in cases are predicted for thyroid (113.8%), prostate (66.7%), female breast (63.0%) and colorectal cancer (54.1%). Breast, colorectal and stomach cancers were the most common cancers in Iran in 2016 and are predicted to remain the leading cancers nationally in 2025. The increasing trends in incidence of most common cancers in Iran reinforce the need for the tailored design and implementation of effective national cancer control programs across the country.
Our results indicate that increased frequency of intake of bread, rice, and red meat (especially barbecued) and deep fried vegetables can aggregate PC risk, while increased frequency of fish consumption can protect against PC. However, more studies are still needed.
BACKGROUND
Information regarding solid pseudopapillary neoplasm (SPN) of the pancreas
is limited in Iran. We aimed to review the clinicocytopathological features and
follow-up of patients with SPN of pancreas who were diagnosed in a single
center in Iran.
METHODS
Seven patients with SPN of the pancreas were diagnosed during January
2010 to March 2015 at the Digestive Disease Research Institute of Tehran University
of Medical Sciences. The patients were reviewed prospectively.
RESULTS
Six out of the 7 patients were female and the mean age of all the patients
was 29.4 years ranging from 15 to 61 years. The most common clinical presentation
was nonspecific abdominal pain (N=6). The tumors were located
mostly in head and neck of the pancreas. SPN was diagnosed in all patients
by fine needle aspiration through endosonography (EUS-FNA). All patients
underwent surgery. Histological findings of surgical tissues were consistent
with EUS-FNA. The postoperative follow-up period of about 14 months was
uneventful.
CONCLUSION
SPN of the pancreas is a rare pancreatic tumor which affects primarily
young women. EUS-guided FNA could play an important role in preoperative
diagnosis of SPN of the pancreas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.